Clicky

Takeda Pharmaceutical Company Limited(TAKP34) News

Date Title
Jan 16 U.S. FDA Approves Takeda’s HYQVIA® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)